Search Results for "Tailand Swine Influenza Vaccine Market"

19:02 EST 7th December 2016 | BioPortfolio

Matching Channels

Matching News

H1N1 'Swine Flu' Vaccine Unlikely to Raise Birth Defect Risk

MONDAY, Sept. 19, 2016 -- Swedish researchers report that the vaccine against the H1N1 "swine flu" strain of influenza doesn't seem to have a link to birth defects. One obstetrician who reviewed the r...

Influenza-Neutralizing Antibodies Generated in Human Subjects Given an Experimental Vaccine

Influenza A viruses are responsible for seasonal disease outbreaks in humans. Influenza A also circulates among bird and some mammal populations and periodically crosses between species. The influenza...

Influenza vaccine market to grow to £4.3 billion by 2025

GlobalData has released new findings which indicate that the seasonal influenza vaccine market is set to be worth $4.3 billion by 2025 across the seven major markets: US, UK, France, Italy, Germany, S...

MHRA approves Sanofi Pasteur MSD’s four-strain influenza vaccine for UK use

Sanofi Pasteur MSD has announced the approval of the latest addition to its family of influenza vaccines in the UK: the quadrivalent influenza vaccine (split virion, inactivated). The vaccine contains...

ACIP Nixes Nasal Spray Influenza Vaccine for Next Season

The CDC's ACIP has recommended that live attenuated influenza vaccine, the nasal spray influenza vaccine, should not be used because it was ineffective during the last three influenza seasons. Meds...

Global Influenza Vaccine Market Outlook 2022 Prices from USD $2100

The global influenza vaccine industry has reported a significant growth in recent years, and is presenting ample opportunities to the industry's players. With increasing pandemic as well as seasonal o...

FDA Approves Flublok Quadrivalent Influenza Vaccine

NewsProtein Sciences Corporation announced that the FDA has approved its influenza vaccine, which protects against four strains of influenza.

CDC Vaccine Information and Recommendations for the 2016/17 Influenza Season

With the start of a new school year and the approaching winter, it’s time to get informed about the most critical information regarding the 2016/17 influenza vaccines and CDC’s vaccination recomme...

Matching PubMed Articles

Influenza vaccine effectiveness: Maintained protection throughout the duration of influenza seasons 2010-2011 through 2013-2014.

Factors, such as age, comorbidities, vaccine type, herd immunity, previous influenza exposure, and antigenic shift, may impact the immune response to the influenza vaccine, protection against circulat...

Learning to Trust Flu Shots: Quasi-Experimental Evidence from the 2009 Swine Flu Pandemic.

This paper studies consumer learning in influenza vaccination decisions. We examine consumer learning in influenza vaccine demand within a reduced form instrumental variable framework that exploits di...

Influenza B vaccine lineage selection-An optimized trivalent vaccine.

Epidemics of seasonal influenza viruses cause considerable morbidity and mortality each year. Various types and subtypes of influenza circulate in humans and evolve continuously such that individuals ...

Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: A systematic review and meta-analysis of randomised controlled trials.

A quadrivalent influenza vaccine (QIV) includes two A strains (A/H1N1, A/H3N2) and two B lineages (B/Victoria, B/Yamagata). The presence of both B lineages eliminate potential B lineage mismatch of tr...

Predictors of influenza vaccine uptake during the 2009/10 influenza A H1N1v ('swine flu') pandemic: Results from five national surveys in the United Kingdom.

To investigate reasons underlying the low uptake of the influenza A H1N1v vaccination in the UK during the 2009/10 pandemic.

Search Whole site using Google

Quick Search
Advertisement Advertisement